by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Oct 17, 2012 | Medicare Drug Plans
Open enrollment for Medicare Part D (Drug Plans) began this week. If you are eligible for Medicare Part D, and want to sign up for a plan or change your current plan, you should be sure to find the plan that works best for you.
Be sure to check out MedicareDrugPlans.com to compare and contrast plans; and don’t worry – plan ratings are completely objective, as we are not affiliated with any plan. In fact, the ratings are provided by people who actually use the plans, based on criteria like deductible, monthly premium, drug coverage, and customer service. Perhaps even more helpful than the ratings are the written reviews where Medicare Part D enrollees explain their experiences with plans, often expressing frustration with formularies that change mid-year, problems at the pharmacy using the plans, or copay issues. If you want to recommend (or steer people away from) a plan, make sure to leave a rating and review.
Once you’ve chosen a plan based on ratings and reviews, head to the government’s site, Medicare.gov to make sure the plan covers your medications, compare final costs and sign up for it. The average premium nationally is $53.55, which is down over a dollar than last year. The maximum drug deductible is $325, up $5 from last year
There are changes for enrollees who enter the coverage gap (“donut hole”) this year. While some plans do offer gap coverage for generics and brand name medication, most do not. However, once you enter the donut hole, you get a 50% discount on covered brand-name drugs, though the drug’s whole value will go towards closing the gap.
As open enrollment begins, Medicare enrollees interested in a drug plan are urged to research carefully. Whatever plan you choose will go into effect starting January 1st, 2013 and last for one full year – so get it right! Visit MedicareDrugPlans.com now!
Tagged with: Medicare Drug Plans, Medicare Part D, medicaredrugplans.com
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Oct 11, 2012 | Drug Prices, Medication non-adherence
A major U.S. pharmacy has finally said that high drug prices are the biggest barrier to medication adherence. A recent study from CVS Caremark revealed that 62% of pharmacists said high drug prices are the most common cause of prescription nonadherence (not taking your meds) among their patients. Ninety-one percent of pharmacists said that cost efficient alternatives to expensive therapies would improve adherence.
While previous studies from the pharmaceutical and pharmacy industries have mentioned that that cost is a barrier to medication, this is the first industry study to our knowledge that says cost is the primary barrier. Oddly enough, the pharmacy industry, including CVS and Caremark, is one of the industries profiting from high drug prices.
High drug prices are bad for public health. Medication adherence is linked to 125,000 deaths and 290 billion dollars in excess health spending per year (hospitalizations and emergency room spending, among others). High drug prices cause a large part of this – 48 million Americans did not fill a prescription due to cost in 2010.
Americans – both as patients and taxpayers – deserve access to low cost medication. As patients, our health is on the line. As taxpayers we are funding hospital stays and emergency room visits. Lower drug prices are needed in America – and the benefits go beyond simply having extra cash in your pocket.
And as far as savings go, remember to ask your pharmacist how to save. Generic medications, discount cards, and coupons offer some savings. For brand name medications without generic alternatives, you’ll find the best savings at an online pharmacy. Just make sure it’s safe and credentialed, like those listed on PharmacyChecker.com. Whatever you do, don’t forgo needed prescription medication.
Tagged with: CVS Caremark, Drug Prices, Medication non-adherence, Online Pharmacy
by Gabriel Levitt, Vice President, PharmacyChecker.com and Sam Werbalowsky, Pharmacychecker.com | Jul 31, 2012 | Drug Prices, Pharmaceutical Industry, Politics
Picture from CNN coverage of the Medicaid Fraud
The pharmaceutical industry and FDA seem to want us to buy medicine at high prices. They say it’s dangerous to import cheaper medicine, even though it’s been shown to be safe when done through pharmacies approved by PharmacyChecker.com. In fact, recent events show that their supported high drug prices can cause major drug safety problems right here at home.
Forty-eight people in a nationwide Medicaid fraud syndicate were recently arrested for buying prescription drugs from Medicaid recipients and re-selling them. The medications included Zyprexa for Schizophrenia, Atripla and Trivizir for HIV/AIDS, and also asthma medications. As reported in the Wall Street Journal and CNN, the drugs made their way through a black market to a supply chain of “collectors” and “aggregators”, eventually working their way into wholesale companies and pharmacies in New York, New Jersey, Pennsylvania, Massachusetts, Utah, Nevada, Louisiana, and Alabama. The medications were also sold in bodegas on the street.
Medicaid fraud is not new but the scope of this will cost taxpayers $500,000,000. The scariest thing about this fraud is that the drugs made it into licensed pharmacies throughout the United States. These drugs could have been adulterated, mishandled, or improperly stored – they may no longer be safe.
What lessons should we learn from this? Here are two to consider:
- High drug prices helped create this black market, weakening the U.S. drug supply
- As a result, American taxpayers bear the burden of higher healthcare costs.
High drug prices helped create this black market, weakening the U.S. drug supply
Medicaid patients sold their drugs because it was highly profitable, despite consequences to their own health. Pharmacies bought from black market wholesalers because their prices were cheaper. End-users bought medicine they needed from bodegas and street corners because it was cheaper than a trip to the pharmacy.
In countries with much lower drug prices there is less incentive for this type of fraud. We’ve made price comparisons among the types of prescription drugs fraudulently sold in the U.S. by looking at U.S. and international pharmacy prices.
Savings On Popular Medications Found in Fraud
Drug |
US Bricks-and –Mortar price |
Lowest International Price Found on PharmacyChecker.com |
Savings |
Percent Savings |
1 year savings |
Atripla |
$18,000.00 |
$4,012.20 |
$13,987.80 |
77.71% |
$55,951.20 |
Truvada |
$4,500.00 |
$1,716.00 |
$2,784.00 |
61.87% |
$11,136.00 |
Zyprexa Generic 5mg |
$1,161.00 |
$40.50 |
$1,120.50 |
96.51% |
$4,482.00 |
Advair 250-50 mcg |
$947.97 |
$139.00 |
$808.97 |
85.34% |
$3,235.88 |
All prices collected on 7/19/2012. Bricks-and-Mortar pharmacy located in New York City
American taxpayers bear the burden of higher healthcare costs:
We paid taxes for Medicaid beneficiaries to not take their medicine as prescribed, and to instead sell their medicine. We paid the costs of hospitalization and emergency room visits for these people who went without needed medication and maybe even the end-users, who took potentially adulterated medicine.
It’s also likely that Medicaid was double-billed for the same exact pills: the first time when a Medicaid recipient received it; the second time when it was dispensed again from another pharmacy that received it from black market channels.
Despite problems with our distribution system, the U.S. has one of the world’s safest pharmaceutical supplies. However, the U.S. is not alone in having safe medication – not even close. The pharmaceutical industry and their supported groups fool consumers, elected officials and the media into believing that online pharmacies outside the United States are all dangerous, which, to be polite, is factually inaccurate. Let’s bring some balance to the issue and look at the drug supply problems in our own backyard. The problems here are serious, too, and fraud like this could even be prevented if there were easier access to safe and affordable medication.
Tagged with: Drug Prices, FDA, Fraud, medicaid